These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8526689)

  • 1. The costs of antihypertensive therapy.
    Kaplan NM
    Arch Intern Med; 1996 Jan; 156(1):110-1. PubMed ID: 8526689
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is the cost of hypertension treatment to society?].
    Aberg H
    Lakartidningen; 1991 Mar; 88(12):1055-6. PubMed ID: 2016931
    [No Abstract]   [Full Text] [Related]  

  • 3. Roundtable discussion: Part II--Development of a pharmacoeconomic model in hypertension.
    Penna P; Cox E; Joseph T; Lehman L; Morrow T; Richter A; Sowers J; Tepper D
    Manag Care Interface; 2000; Suppl C():17-23. PubMed ID: 11183935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New guidelines for the treatment of hypertension--what has really happened since the last time?].
    Hjemdahl P
    Lakartidningen; 1990 Sep; 87(39):3068-9. PubMed ID: 2215021
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug expenditures for hypertension: an empirical test of an economic model in a French population.
    Huttin C; Avorn J
    Cah Sociol Demogr Med; 1997; 37(1):33-52. PubMed ID: 9239318
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin receptor blockers: impact on costs of care.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effective therapy for hypertension.
    Barrie W
    West J Med; 1996 Apr; 164(4):303-9. PubMed ID: 8732729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of antihypertensive drugs in Spain (1995-2001)].
    García del Pozo J; Ramos Sevillano E; de Abajo FJ; Mateos Campos R
    Rev Esp Cardiol; 2004 Mar; 57(3):241-9. PubMed ID: 15056428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension.
    Arrandale KE; Navarro RP; Cave DG
    Manag Care Interface; 1998 Jan; 11(1):50-2. PubMed ID: 10178970
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of mandatory prescribing of thiazides for newly treated, uncomplicated hypertension: interrupted time-series analysis.
    Fretheim A; Håvelsrud K; MacLennan G; Kristoffersen DT; Oxman AD
    PLoS Med; 2007 Jul; 4(7):e232. PubMed ID: 17622192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension control: improved, but not enough!
    Alderman MH
    Am J Hypertens; 2007 Apr; 20(4):347. PubMed ID: 17386338
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with antihypertensive therapy: raising the bar of expectations.
    Rudd P
    Am J Manag Care; 1998 Jul; 4(7):957-66. PubMed ID: 10181995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic considerations that influence health policy and research.
    Harlan WR
    Hypertension; 1989 May; 13(5 Suppl):I158-63. PubMed ID: 2490820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication therapy in office visits for hypertension: National Ambulatory Medical Care Survey, 1980.
    Cypress BK
    Adv Data; 1982 Jul; (80):1-11. PubMed ID: 10256440
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
    Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
    Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacoeconomic aspects of the treatment of essential hypertension].
    Martynov AI; Giliarevskiĭ SR; Ostroumova OD; Nesterova MV; Mamaev VI
    Ter Arkh; 2001; 73(9):82-8. PubMed ID: 11642090
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of drug cost on hypertension treatment decision.
    Salman H; Bergman M; Hart J; Neuman V; Zevin D; Bessler H; Djaldetti M
    Public Health; 1999 Sep; 113(5):243-6. PubMed ID: 10557119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.